Sidra Zafar

Clinical Research Associate
National Institute of Blood Diseases and Bone Marrow Transplantation

Presentation(s):

• PB0650 - To predict the impact of low dose prophylaxis vs. on demand treatment in severe Hemophilia A patients in Pakistan

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB0651 - Health-Related Quality-of-Lives in Hemophilia A patients on prophylactic therapy of Emicizumab (Hemlibra)

  Monday, July 11, 2022
  6:30 PM – 7:30 PM

• PB0847 - Management of adult idiopathic thrombocytopenic purpura (ITP) patients with antinuclear antibody (ANA)

  Monday, July 11, 2022
  6:30 PM – 7:30 PM